Drug Trial Radar · NCT05844449
Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older
Last checked: Nov 19, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
174
Planned (sponsor's estimate)
Start
Aug 11, 2023
Primary completion
Jul 30, 2029
Study completion Jul 30, 2029
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- May 6, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 year
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of vanzacaftor/tezacaftor/deutivacaftor (VNZ/TEZ/D-IVA) in participants with cystic fibrosis (CF).
Conditions
- Cystic Fibrosis
Interventions
VNZ/TEZ/D-IVADrug
Fixed-dose combination tablets or granules for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs)Time frame: From Baseline up to Week 100
- Part B: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs)Time frame: From Baseline up to Week 196
Locations
37 sites in 10 countries. Site status is shown where the registry gives one.
Children's Hospital of Orange County
Orange, California
Stanford University - Palo Alto - Pulmonology
Palo Alto, California
Children's Hospital of Colorado - Pulmonology
Aurora, Colorado
The Emory Clinic - Clifton Road - Pulmonology
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago - Hematology
Chicago, Illinois
JW Riley Hospital for Children - Pulmonology
Indianapolis, Indiana
Boston Children's Hospital
Boston, Massachusetts
Children's Health Care d/b/a Children's Hospitals and Clinics of Minnesota
Minneapolis, Minnesota
The Children's Mercy Hospital
Kansas City, Missouri
St. Louis Children's Hospital - Pulmonology
St Louis, Missouri
Cohen Children's Medical Center - Lakeville Road
Lake Success, New York
Cincinnati Children's Hospital Medical Center - Pulmonology
Cincinnati, Ohio
UH Cleveland Medical Center - Pulmonology
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
Children's Hospital of Pittsburgh - Pulmonology
Pittsburgh, Pennsylvania
Texas Children's Hospital - Wallace Tower - Pulmonology
Houston, Texas
Vermont Lung Center
Colchester, Vermont
American Family Childrens Hospital
Madison, Wisconsin
The Kids Research Institute Australia
Nedlands, Australia
Women's & Children's Hospital
North Adelaide, Australia
The Royal Children's Hospital Melbourne
Parkville, Australia
Children's Health Queensland Hospital and Health Service
South Brisbane, Australia
Hospital for Sick Children - Pulmonology
Toronto, Canada
British Columbia Children's Hospital
Vancouver, Canada
Hopital Femme Mere-Enfant
Bron, France
Hopital Necker Enfants Malades - Pulmonology
Paris, France
Charite Paediatric Pulmonology Department
Berlin, Germany
Universitatsklinikum Essen
Essen, Germany
Medizinische Hochschule Hannover - Clinic for Pediatric Pneumology, Allergology and Neonatology, CF-Centre
Hanover, Germany
Sophia Children's Hospital
Rotterdam, Netherlands
Starship Child Health
Grafton, New Zealand
Sahlgrenska Universitetssjukhuset - Göteborg CF-center
Gothenburg, Sweden
Karolinska University Hospital - Pulmonology
Stockholm, Sweden
Inselspital Bern
Bern, Switzerland
Kinderspital Zurich - Abteilung Pneumologie
Zurich, Switzerland
Noah's Ark Children's Hospital for Wales
Cardiff, United Kingdom
Great Ormond Street Hospital for Children
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.